EvolveImmune Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

  • EvolveImmune Therapeutics's estimated annual revenue is currently $3.5M per year.(i)
  • EvolveImmune Therapeutics's estimated revenue per employee is $70,000

Employee Data

  • EvolveImmune Therapeutics has 50 Employees.(i)
  • EvolveImmune Therapeutics grew their employee count by 28% last year.

EvolveImmune Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Senior Adviser to CEO at EvolveImmune TherapeuticsReveal Email/Phone
3
VP Research and DevelopmentReveal Email/Phone
4
SVP CMC and Manufacturing OperationsReveal Email/Phone
5
SVP, Global Head Oncology and Hematology Drug Development - Genentech Roche, Former Physician-in-Chief Yale-Smilow Cancer CenterReveal Email/Phone
6
Senior Director, Analytical DevelopmentReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Director, BiotherapeuticsReveal Email/Phone
9
Chief Business OfficerReveal Email/Phone
10
Senior Director, Development Program and Alliance ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M5028%N/AN/A
Add Company

What Is EvolveImmune Therapeutics?

keywords:N/A

N/A

Total Funding

50

Number of Employees

$3.5M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7M506%N/A
#2
$6.9M506%N/A
#3
$7.5M504%N/A
#4
$14.8M500%N/A
#5
$9.8M50-4%N/A